Emcure Pharmaceuticals Signs Licensing Agreement for HIV Treatment Drug
Gilead Sciences Hits 36-week High
Dr. Reddy's Signs Voluntary Licensing Agreement With Gilead Sciences To Manufacture And Commercialise Lenacapavir In India And Other Countries
Express News | DR. Reddy’s Signs Voluntary Licensing Agreement With Gilead Sciences to Manufacture and Commercialise Lenacapavir in India and Other Countries
Hetero Signs Voluntary Licensing Agreement With Gilead to Transform Global HIV Response, Expanding Access to Groundbreaking Lenacapavir to 120 High-incidence Countries
Gilead Signs Deals With Six Drugmakers for Generic Lenacapavir
Express News | Gilead Sciences Inc - Generic Manufacturers Include DR. Reddy's, Emcure, Eva Pharma, Ferozsons, Hetero, Mylan
Express News | Gilead Sciences Inc - to Price Lenacapavir at No Profit Until Generic Supply
Express News | Gilead Signs Royalty-Free Voluntary Licensing Agreements With Six Generic Manufacturers to Increase Access to Lenacapavir for Hiv Prevention in High-Incidence, Resource-Limited Countries
Gilead Signs Royalty-Free Voluntary Licensing Agreements With Six Generic Manufacturers to Increase Access to Lenacapavir for HIV Prevention in High-Incidence, Resource-Limited Countries
$1000 Invested In This Stock 20 Years Ago Would Be Worth $8,800 Today
Gilead Sciences, Inc. (NASDAQ:GILD) Is a Favorite Amongst Institutional Investors Who Own 86%
Stocks With the Highest Consensus of Expected ROE Growth, Goldman Sachs Says
Here Are the Medicare Part D Drugs Expected to Face 2025 Price Negotiations
Gilead Sciences (GILD) Stock Slides as Market Rises: Facts to Know Before You Trade
Top 4 Health Care Stocks That May Keep You Up At Night
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD) and Johnson & Johnson (JNJ)
Gilead Sciences Recalls One Lot Of Its COVID-19 Treatment Due To Presence Of Glass Particles
FDA Says Gilead Issues Voluntary Nationwide Recall Of One Lot Of Veklury For Injection 100 Mg/Vial Due To The Presence Of A Glass Particle
Express News | FDA: Gilead Issues Voluntary Nationwide Recall of One Lot of Veklury (Remdesivir) for Injection 100 Mg/Vial Due to the Presence of a Glass Particle